Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
lucinactant (Surfaxin)
print preview
bookmark
share with colleague
General Information
Company
Discovery Laboratories Inc.
Description
Humanized lung surfactant
Molecular Target
Not applicable
Mechanism of Action
NA
Latest Stage of Development
Approved
Indication
Respiratory distress syndrome (RDS)
Partner
Esteve S.A.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy